Sally M. Hunter

1.8k total citations
20 papers, 852 citations indexed

About

Sally M. Hunter is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Genetics. According to data from OpenAlex, Sally M. Hunter has authored 20 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Cancer Research and 7 papers in Genetics. Recurrent topics in Sally M. Hunter's work include Cancer Genomics and Diagnostics (8 papers), Ovarian cancer diagnosis and treatment (7 papers) and Renal cell carcinoma treatment (5 papers). Sally M. Hunter is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Ovarian cancer diagnosis and treatment (7 papers) and Renal cell carcinoma treatment (5 papers). Sally M. Hunter collaborates with scholars based in Australia, Canada and United States. Sally M. Hunter's co-authors include Ian Campbell, Georgina L. Ryland, Simone M. Rowley, Kylie L. Gorringe, Jason Li, David D.L. Bowtell, Maria Doyle, Michael Christie, Prue E. Allan and Andrew N. Stephens and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Sally M. Hunter

18 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sally M. Hunter Australia 14 413 275 248 199 192 20 852
Keisuke Kurose Japan 14 634 1.5× 128 0.5× 310 1.3× 312 1.6× 127 0.7× 30 1.0k
David G. Huntsman Canada 6 244 0.6× 211 0.8× 135 0.5× 186 0.9× 244 1.3× 6 656
Arisa Ueki Japan 19 386 0.9× 160 0.6× 341 1.4× 213 1.1× 108 0.6× 66 870
Michael Churchman United Kingdom 21 473 1.1× 371 1.3× 223 0.9× 409 2.1× 98 0.5× 45 1.1k
Cindy A. Pise-Masison United States 5 497 1.2× 371 1.3× 320 1.3× 158 0.8× 118 0.6× 6 820
Sheena Scroggins United States 5 449 1.1× 351 1.3× 295 1.2× 550 2.8× 120 0.6× 5 966
Alexandr O. Ivantsov Russia 16 257 0.6× 91 0.3× 248 1.0× 360 1.8× 263 1.4× 51 715
Anna P. Sokolenko Russia 21 643 1.6× 185 0.7× 380 1.5× 383 1.9× 163 0.8× 93 1.3k
Kanji Kobayashi Japan 11 360 0.9× 110 0.4× 357 1.4× 240 1.2× 48 0.3× 17 772
Hyun S. Shvartsman United States 9 355 0.9× 438 1.6× 86 0.3× 194 1.0× 55 0.3× 10 785

Countries citing papers authored by Sally M. Hunter

Since Specialization
Citations

This map shows the geographic impact of Sally M. Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally M. Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally M. Hunter more than expected).

Fields of papers citing papers by Sally M. Hunter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally M. Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally M. Hunter. The network helps show where Sally M. Hunter may publish in the future.

Co-authorship network of co-authors of Sally M. Hunter

This figure shows the co-authorship network connecting the top 25 collaborators of Sally M. Hunter. A scholar is included among the top collaborators of Sally M. Hunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally M. Hunter. Sally M. Hunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tiong, Ing Soo, Sally M. Hunter, Nicole den Elzen, et al.. (2025). Genomic variation in DDX41 identified through clinical sequencing. British Journal of Haematology. 207(4). 1653–1658.
2.
Hunter, Sally M., Genevieve Dall, Maria Doyle, et al.. (2020). Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours. BMC Research Notes. 13(1). 349–349. 7 indexed citations
3.
Gorringe, Kylie L., Sally M. Hunter, Jia‐Min Pang, et al.. (2015). Copy number analysis of ductal carcinoma in situ with and without recurrence. Modern Pathology. 28(9). 1174–1184. 31 indexed citations
4.
Hunter, Sally M., Simone M. Rowley, David Clouston, et al.. (2015). Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer. Urologic Oncology Seminars and Original Investigations. 34(3). 120.e9–120.e16. 4 indexed citations
5.
Ryland, Georgina L., Sally M. Hunter, Maria Doyle, et al.. (2015). Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors. Genome Medicine. 7(1). 87–87. 109 indexed citations
6.
Hunter, Sally M., Michael S. Anglesio, Georgina L. Ryland, et al.. (2015). Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes. Oncotarget. 6(35). 37663–37677. 130 indexed citations
7.
Takano, Elena A., Sally M. Hunter, Ian Campbell, & Stephen B. Fox. (2015). Low-grade fibromatosis-like spindle cell carcinomas of the breast are molecularly exiguous. Journal of Clinical Pathology. 68(5). 362–367. 14 indexed citations
8.
Amarasinghe, Kaushalya, Jason Li, Sally M. Hunter, et al.. (2014). Inferring copy number and genotype in tumour exome data. BMC Genomics. 15(1). 732–732. 84 indexed citations
9.
Hunter, Sally M., et al.. (2014). Genomic Aberrations of BRCA1-Mutated Fallopian Tube Carcinomas. American Journal Of Pathology. 184(6). 1871–1876. 1 indexed citations
10.
Li, Jason, Maria Doyle, Isaam Saeed, et al.. (2014). Bioinformatics Pipelines for Targeted Resequencing and Whole-Exome Sequencing of Human and Mouse Genomes: A Virtual Appliance Approach for Instant Deployment. PLoS ONE. 9(4). e95217–e95217. 18 indexed citations
11.
Risbridger, Gail P., Renea A. Taylor, David Clouston, et al.. (2014). Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis. European Urology. 67(3). 496–503. 96 indexed citations
12.
Goode, David L., Sally M. Hunter, Maria Doyle, et al.. (2013). A simple consensus approach improves somatic mutation prediction accuracy. Genome Medicine. 5(9). 90–90. 23 indexed citations
13.
Hunter, Sally M., Kylie L. Gorringe, Michael Christie, et al.. (2012). Pre-Invasive Ovarian Mucinous Tumors Are Characterized by CDKN2A and RAS Pathway Aberrations. Clinical Cancer Research. 18(19). 5267–5277. 52 indexed citations
14.
Ryland, Georgina L., Sally M. Hunter, Maria Doyle, et al.. (2012). RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. The Journal of Pathology. 229(3). 469–476. 88 indexed citations
15.
Hunter, Sally M., Michael S. Anglesio, Raghwa Sharma, et al.. (2011). Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification?. Clinical Cancer Research. 17(23). 7273–7282. 17 indexed citations
16.
Syrzycka, Monika, Samantha Beck, James A. Kennison, et al.. (2008). The Drosophila cohesin subunit Rad21 is a trithorax group (trxG) protein. Proceedings of the National Academy of Sciences. 105(34). 12405–12410. 54 indexed citations
17.
Hunter, Sally M.. (2004). NASN is on the Move to Washington D.C. 19(6). 15–15.
18.
Friedman, Lori S., Fiona Thistlethwaite, Veronica Yu, et al.. (1998). Thymic lymphomas in mice with a truncating mutation in Brca2.. PubMed. 58(7). 1338–43. 102 indexed citations
19.
Sanders, D. S. A., et al.. (1989). Argyrophil carcinoma of the breast: A cytologic, histochemical, and ultrastructural study of a case. Diagnostic Cytopathology. 5(2). 217–220. 7 indexed citations
20.
Robinson, Michael F., et al.. (1986). THE PRODUCTION OF HYDROXYL RADICAL BY HUMAN NEUTROPHILS STIMULATED BY ARACHIDONIC ACID – MEASUREMENTS BY ESR SPECTROSCOPY. Immunology and Cell Biology. 64(2). 157–164. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keisuke Kurose Breakdown of academic impact, for papers by David G. Huntsman Breakdown of academic impact, for papers by Arisa Ueki Breakdown of academic impact, for papers by Michael Churchman Breakdown of academic impact, for papers by Cindy A. Pise-Masison Breakdown of academic impact, for papers by Sheena Scroggins Breakdown of academic impact, for papers by Alexandr O. Ivantsov Breakdown of academic impact, for papers by Anna P. Sokolenko Breakdown of academic impact, for papers by Kanji Kobayashi Breakdown of academic impact, for papers by Hyun S. Shvartsman
Rankless by CCL
2026